Recombinant Human AIMP1
EMAP-II is activated during apoptosis by cleavage of pro-EMAP through caspase 8 and enhances the recruitment of inflammatory cells by its chemotactic properties. Besides its chemotactic effect on inflammatory cells, EMAP-II increases the adhesiveness of coronary artery smooth muscle cells (CASMC) for monocytes. EMAP-II also has anti-angiogenic properties, which are explained by its pro-apoptotic effect on endothelial cells.
Product Specifications
CAS Number
9000-83-3
Gene Name
AIMP1
Gene Aliases
Gene ID
9255
Accession Number
Q12904
Organism
Human
Source
E. coli
Concentration
<1.0 EU/μg of recombinant protein as determined by the LAL method.
Purity
>95% as determined by SDS-PAGE
Solubility
Function
The ED(50) was determined by apoptotic effect on MCF-7 cells using a concentration of 10-50 ng/mL.
Molecular Weight
18
Shipping Conditions
Ambient Temperature
Storage Conditions
Appearance
Lyophilized Powder
Formulation
Lyophilized from a 0.2 μm filtered 20 mM PBS,130 mM NaCl solution pH 7.5
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NUP107, ID (NUP107, Nuclear pore complex protein Nup107, 107kD nucleoporin, Nucleoporin Nup107) (MaxLight 750) discontinued
Hepatitis Be Ag (HBeAg, Hepatitis Be) (MaxLight 550)
Hepatitis Be Ag (HBeAg, Hepatitis Be) (MaxLight 550)